Does Rallies show 13F holders for FTRE?

Yes. Rallies tracks hedge fund and 13F ownership data for FTRE, including fund names, share counts, latest tracked quarter, and position changes when available.

Is FTRE research on Rallies investment advice?

No. Rallies provides research, data, and educational context for FTRE. It does not provide personalized investment advice.

FTRE (Fortrea Holdings Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Fortrea Holdings Inc. Common Stock (FTRE) is a publicly traded Healthcare sector company. As of May 21, 2026, FTRE trades at $13.70 with a market cap of $1.29B and a P/E ratio of -1.25. FTRE moved -0.15% today. Year to date, FTRE is -17.57%; over the trailing twelve months it is +192.11%. Its 52-week range spans $3.97 to $25.28. Analyst consensus is buy with an average price target of $15.58. Rallies surfaces FTRE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns FTRE stock?

Hedge funds tracked by Rallies that own FTRE include Corvex Management, Starboard Value, Baupost Group, Jana Partners, and Maverick Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Fortrea Holdings Inc. Common Stock.

FTRE Key Metrics

Key financial metrics for FTRE
Metric	Value
Price	$13.70
Market Cap	$1.29B
P/E Ratio	-1.25
EPS	$-10.81
Dividend Yield	0.00%
52-Week High	$25.28
52-Week Low	$3.97
Volume	738.32K
Avg Volume	0
Revenue (TTM)	$2.72B
Net Income	$-986.20M
Gross Margin	0.00%

Top Hedge Funds Holding FTRE

Corvex Management holds 4.64M shares of FTRE, changed +3.01% as of Mar 31, 2026.
Starboard Value holds 2.50M shares of FTRE, changed -52.63% as of Jun 30, 2025.
Baupost Group holds 2.29M shares of FTRE, changed -26.98% as of Sep 30, 2024.
Jana Partners holds 692.41K shares of FTRE, changed +0.35% as of Sep 30, 2024.
Maverick Capital holds 84.69K shares of FTRE, changed +0.00% as of Sep 30, 2024.

Latest FTRE News

Fortrea Reports $660.5M Q4 Revenue, Sets $2.55B–$2.65B 2026 Revenue Guidance — Feb 26, 2026
Fortrea Names Oren Cohen Chief Medical Officer, Scott Dove Heads Clinical Pharmacology — Feb 17, 2026
Fortrea’s 13.5 P/E and 0.30 PEG Secure A Value Grade Over Prothena — Feb 13, 2026

Recent FTRE Insider Trades

Parks Robert sold 2.00K (~$26.88K) on May 18, 2026.
Morais Mark A. sold 1.80K (~$16.63K) on Mar 16, 2026.
Mcconnell Jill G. sold 1.80K (~$16.63K) on Mar 16, 2026.

FTRE Analyst Consensus

10 analysts cover FTRE: 0 strong buy, 5 buy, 4 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $15.58.

Common questions about FTRE

Who owns FTRE stock?: Hedge funds tracked by Rallies that own FTRE include Corvex Management, Starboard Value, Baupost Group, Jana Partners, and Maverick Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Fortrea Holdings Inc. Common Stock.
Does Rallies show 13F holders for FTRE?: Yes. Rallies tracks hedge fund and 13F ownership data for FTRE, including fund names, share counts, latest tracked quarter, and position changes when available.
Is FTRE research on Rallies investment advice?: No. Rallies provides research, data, and educational context for FTRE. It does not provide personalized investment advice.